期刊文献+

神经生长因子、白血病抑制因子调控支气管哮喘大鼠神经源性炎症机制的研究 被引量:24

Experimental study on the mechanisms of regulating airway neurogenic inflammation in asthma by never growth factor and leukemia inhibitory factor
原文传递
导出
摘要 目的研究神经生长因子(NGF)、白血病抑制因子(LIF)调控支气管哮喘(简称哮喘)大鼠气道神经源性炎症的机制,寻求治疗哮喘的新靶点。方法成年清洁级雄性SD大鼠36只,按随机数字表法分为对照组、哮喘组和抗NGF组,每组12只。采用免疫组织化学和原位杂交技术观察哮喘大鼠肺组织、C7~T5背根神经节内NGF、LIF、P物质(SP)的表达状态及抗NGF干预对其表达的影响。结果(1)哮喘组大鼠肺组织NGF、LIF蛋白及其mRNA的平均灰度值分别为157±7、138±8、156±6、141±10,对照组分别为183±7、190±7、187±7、181±8,抗NGF干预组分别为177±6、169±9、178±7、172±9,三组比较差异有统计学意义(t分别=19.40、15.80、0.38、14.79,P均<0.01);(2)哮喘组大鼠C7~T5背根神经节NGF、LIF、SP蛋白及SPmRNA的灰度值分别为136±8、148±6、140±8、128±8,对照组分别为185±7、187±8、174±7、180±8,抗NGF干预组分别为164±6、170±8、163±9、157±7,三组比较差异有统计学意义(t分别=29.50、22.65、23.12、28.71,P均<0.01)。结论促进背根神经节细胞合成和释放SP可能是NGF、LIF参与哮喘气道神经源性炎症形成的机制之一,抗NGF干预能够有效地将其抑制。 Objective To study the mechanisms of regulating airway neurogenic inflammation in asthma by never growth factor (NGF) and leukemia inhibitory factor (LIF) , and then to explore new targets in treating asthma. Methods Adult male SD rats ( n 36) were divided into the normal group, the asthmatic group and the anti-NGF group at random. There were 12 rats in each group. The asthma models were established by sensitization and challenge with ovalbumin, and the asthma model was treated with anti-NGF. The expression of NGF, LIF and substance P (SP) in lung tissue or in doral root ganglion of each rat were detected by immunohiscbemistry and hybridisation in situ. Results ( 1 ) The gray-levels of NGF protein/ NGF mRNA, LIF protein/LIF mRNA in the lungs were 157±7, 138±8, 156 ± 6, 141± 10 for the asthmatic group respectively, 183±7, 190±7, 187±7, 181±8 for the normal control group respectively, and 177±6, 169±9, 178±7, 172±9 for the asthmatic group with anti-NGF treatment. There were significant differences in gray-level of NGF protein/NGF mRNA, LIF protein/LIF mRNA among those three groups (t = 19.40±15. 80,0. 38±14. 79, all P 〈0.01 ). (2) The gray-levels of NGF protein/LIF protein, SP protein/SP mRNA in the doral root ganglions were 136±8, 148 ±6, 140 ±8, 128±8 for the asthmatic group respectively, 185 ±7, 187±8, 174±7, 180 ±8 for the normal control group respectively, and 164±6, 170±8, 163±9, 157±7 for the asthmatic group with anti-NGF treatment. There were also significant differences in gray-level of NGF protein/LIF protein, SP protein/SP mRNA among those three groups (t = 29.50±22. 65,23.12±28.71, all P 〈0. 01 ). Conclusion Enhancing the synthesis and release of SP in doral root ganglion may be one of the mechanisms by which NGF and LIF regulate airway neurogenic inflammation in asthmatic rats, and this mechanism can be depressed by the intervention of anti-NGF.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2006年第6期376-380,共5页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 国家自然科学基金资助项目(30300146)
关键词 哮喘 神经生长因子 白血病抑制因子 神经源性炎症 Asthma Never grown factor Leukemia inhibitory factor Neurogenic inflammation
  • 相关文献

参考文献8

  • 1Hu C,Wedde-Beer K,Auais A,et al.Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs.Am J Physiol Lung Cell Mol Physiol,2002,283:LA94-L502.
  • 2林敏娟,胡成平,吴鄂生,潘频华.支气管哮喘大鼠肺组织中白血病抑制因子的表达变化[J].中华结核和呼吸杂志,2003,26(11):727-728. 被引量:14
  • 3邢传平,刘斌,董亮.免疫组织化学标记结果的判断方法[J].中华病理学杂志,2001,30(4):318-318. 被引量:206
  • 4Lindsay RM,Harmar AJ.Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons.Nature,1989,337:362-364.
  • 5Woolf CJ.Phenotypic modification of primary sensory neurons:the role of nerve growth factor in the production of persistent pain.Philos Trans R Soc Lond B Biol Sci,1996,351:441-448.
  • 6方秀斌.K物质和速激肽家族[J].神经解剖学杂志,1989,5(2):135-140. 被引量:12
  • 7Zigmond RE,Sun Y.Regulation of neuropeptide expression in sympathetic neurons.Paracrine and retrograde influences.Ann N Y Acad Sci,1997,814:181-197.
  • 8Knight DA,D'Aprile AC,Spalding LJ,et al.Leukaemia inhibitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants.Br J Pharmacol,2000,130:975-979.

二级参考文献6

  • 1吕国平,崔德健,郭英江,谭剑.介绍一种建立大鼠哮喘模型的实验方法[J].中华结核和呼吸杂志,1995,18(6):377-378. 被引量:187
  • 2Knight DA, Lydell CP, Zhou D, et al. Leukemia inhibitory factor (LIF) and LIF receptor in human lung: distribution and regulation of LIF release. Am J Respir Cell Mol Biol, 1999,20:834-841.
  • 3Knight DA, D'Aprile AC, Spalding LJ, et al. Leukemia inhitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants. Br J Pharmacol, 2000,130:975-979.
  • 4Zheng XY, Knight DA, Zhou D, et al. Leukemia inhibitory factor is synthesized and released by human eosinophils and modulates activation state and chemotaxis. J All Clin Immunol, 1999,104:136-144.
  • 5Tofaris GK, Patterson PH, Jessen KP, et al. Denervated schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci, 2002,22:6696-6703.
  • 6Ikezono T, Wu T, Yao XL, et al. Leukemia inhibitory factor induces the 85-kDa cytosolic phospholipase A2 gene expression in cultured human bronchial epithelial cells. Biochim Biophys Acta, 1997,1355:121-130.

共引文献229

同被引文献312

引证文献24

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部